http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102872069-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac31afbea1cbbb03498644721ffb4a62
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc9613789c35ff3b409910828d6498cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_719b0310d7da41ad2fcd37b6576318a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be67a8a80230cdd4b76514f81e83a79c
publicationDate 2013-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102872069-B
titleOfInvention Application of Houttuynoid C to preparing drugs for treating liver cancer
abstract The invention discloses application of Houttuynoid C to preparing drugs for treating liver cancer, belonging to the technical field of new uses of the drugs. According to the invention, found by in vitro methyl thiazolyl tetrazolium (MTT) antineoplastic activity evaluation, Houttuynoid C also has remarkable inhibition effect on the growth of human hepatoma cell lines HepG2, MHCC-LM3, Bel-7402 andHuH-7. Therefore, Houttuynoid C can be used for preparing the drugs for resisting the liver cancer and has good development and application prospects. The application of Houttuynoid C to preparing the drugs for treating the liver cancer, disclosed by the invention, is firstly published; the framework type is brand new; and the activity of inhibiting the liver cancer cells is unexpectedly strong.
priorityDate 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID16752
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID16752
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412228694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148919969

Total number of triples: 19.